Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Adding a long‑acting local anesthetic to a steroid injection after arthroscopic rotator cuff repair for shoulder adhesion

Official title: Safety and Efficacy of Platelet-Rich Plasma Combined With Compound Betamethasone in Arthroscopic Surgery for Rotator Cuff Injury With Shoulder Adhesion: A Prospective, Multicenter, Randomized Controlled Trial

Run by Second Affiliated Hospital of Nanchang University · NCT07348016 · Data updated 2026-11-12

We will test whether adding liposomal bupivacaine to a standard intra‑articular steroid injection helps adults having arthroscopic rotator cuff repair with shoulder adhesion have less pain and better shoulder function.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment70 (estimated)
SponsorSecond Affiliated Hospital of Nanchang University
Academic / other
Locations1 site (Nanchang, Jiangxi)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedJuly 30, 2027
Study endsDecember 1, 2028
Registry record updatedJanuary 16, 2026
Trial IDNCT07348016 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 with MRI‑confirmed full‑thickness rotator cuff tear and concomitant shoulder adhesion who are scheduled for arthroscopic repair and capsular release and can consent and attend follow‑up are ideal candidates.

Probably not a fit

Patients with massive irreparable tears, severe glenohumeral osteoarthritis, prior shoulder infection or surgery on the affected side, allergies to the study drugs, systemic inflammatory arthritis, or bleeding disorders are unlikely to benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, double‑blind, parallel‑group trial enrolling about 70 adults with full‑thickness rotator cuff tear and shoulder adhesion undergoing arthroscopic repair and capsular release. Participants are randomized to receive either a combination injection of liposomal bupivacaine plus compound betamethasone or compound betamethasone alone into the joint at the end of surgery. Patients and outcome assessors are blinded, and follow‑up visits occur through 12 months with assessments at multiple time points. The primary outcome is the UCLA Shoulder Score, with secondary outcomes including VAS pain scores, Constant‑Murley score, active range of motion, MRI tendon healing (SNQ), and complication rates.

Why it matters

Potential benefit: If successful, the combination injection could reduce postoperative pain and stiffness and improve recovery of shoulder function after rotator cuff repair.

How similar studies have gone: Previous work on liposomal bupivacaine for postoperative shoulder pain has reported mixed results and combining intra‑articular steroids is common but not definitively proven for preventing adhesion‑related stiffness, so this specific combination is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age between 18 and 70 years.

Clinical and MRI diagnosis of full-thickness rotator cuff tear.

Presence of shoulder stiffness/adhesion defined as passive range of motion less than 100° in forward flexion and/or less than 10° in external rotation (or according to your specific definition).

Scheduled for arthroscopic rotator cuff repair and capsular release.

Willing and able to provide written informed consent.

Willing to comply with all study procedures and follow-up visits.

Exclusion Criteria :

Massive, irreparable rotator cuff tear.

Severe glenohumeral osteoarthritis (Grade III or IV according to Samilson-Prieto classification).

History of shoulder infection, fracture, or previous surgery on the affected shoulder.

Known allergy or contraindication to betamethasone, local anesthetics, or components of PRP preparation.

Systemic inflammatory arthritis (e.g., rheumatoid arthritis).

Coagulation disorders or use of anticoagulants that cannot be safely suspended perioperatively.

Pregnancy or lactation.

Participation in another clinical trial within the past 3 months.

Any medical or psychiatric condition that, in the investigator's opinion, would compromise patient safety or compliance with the study protocol.

Where it's running

  • The Second Affiliated Hospital of Nanchang University
    Nanchang, Jiangxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.